Buscar en
Endocrinología y Nutrición (English Edition)
Toda la web
Inicio Endocrinología y Nutrición (English Edition) Reference values for thyroid hormones in the population of pregnant women in Jae...
Journal Information
Vol. 58. Issue 2.
Pages 62-67 (February 2011)
Share
Share
Download PDF
More article options
Vol. 58. Issue 2.
Pages 62-67 (February 2011)
Original Article
Full text access
Reference values for thyroid hormones in the population of pregnant women in Jaen (Spain)
Valores de referencia de hormonas tiroideas en la población de mujeres gestantes de Jaén
Visits
2088
Piedad Santiagoa,
Corresponding author
, María Berrioa, Pablo Olmedob, Inés Velascoc, Baltasar Sáncheza, Eduardo Garcíad, Julia Martíneza, Federico Soriguerd
a UGC de Endocrinología, UGC de Análisis Clínicos y Servicio de Radiología, Complejo Hospitalario de Jaén, Jaén, Spain
b Distrito Sanitario de Jaén, Jaén, Spain
c Servicio de Ginecología y Obstetricia, Hospital de Riotinto, Huelva, Spain
d Servicio de Endocrinología, Hospital Civil de Málaga, Málaga, Spain
This item has received
Article information
Abstract
Objective

To assess thyroid function in the three trimesters of pregnancy in healthy women taking iodine supplements and to define the normal reference ranges in this population.

Design

Descriptive study of pregnant women to define the normal ranges of thyroid hormones in this population.

Setting

Jaen and Osuna (Spain).

Population

Healthy pregnant women.

Methods

Thyroid hormone measurement in the three trimesters of pregnancy in healthy women taking iodine supplements.

Results

A total of 429 pregnant women were given iodine supplements to maintain urinary iodine levels within the normal range. FT4 levels ranged from 0.60 to 1.06ng/dL in the first trimester, from 0.43 to 0.85ng/dL in the second, and from 0.40 to 0.82ng/dl in the third trimester. Reference values of thyroid stimulating hormone (TSH) ranged from 0.23 to 4.18μIU/mL in the first trimester, from 1.78 to 3.89μIU/mL in the second, and from 2.01 to 4.30μIU/mL in the third trimester. FT3 levels ranged from 2.33 to 3.84pg/mL in the first trimester, from 2.04 to 3.51pg/mL in the second, and from 1.99 to 3.46pg/mL in the third trimester.

Conclusion

Taking into account the 3rd and 97th percentiles, the reference ranges in our population were far below those recommended by our reference laboratory. In view of these results, these values should be redefined to avoid misdiagnosis of hypothyroxinemia in healthy pregnant women.

Keywords:
Thyroid hormones
Pregnancy
Normal ranges
Iodine intake
Resumen
Objetivo

Valorar la función tiroidea en los tres trimestres de gestación en mujeres sanas suplementadas con yodo y definir los límites de referencia de la normalidad de esta población.

Diseño

Estudio descriptivo sobre la mujer gestante para definir los límites de normalidad de hormonas tiroideas en esta población.

Emplazamiento

Jaén y Osuna.

Población

Gestantes sanas.

Métodos

Determinación de hormonas tiroideas en los tres trimestres de gestación en mujeres sanas suplementadas con yodo.

Resultados

Cuatrocientas veintinueve gestantes fueron suplementadas con yodo para mantener nivel de yoduria en los límites de normalidad. Las concentraciones de T4-l estuvieron entre 0,60 y 1,06 para el primer trimestre, entre 0,43 y 0,85ng/dl en el segundo trimestre y entre 0,40 y 0,82ng/dl en el tercer trimestre. Para la TSH los valores de referencia son: 0,23 y 4,18μUI/ml en el primer trimestre, 1,78 y 3,89μUI/ml en el segundo trimestre y 2,01 y 4,30μUI/ml en el tercer trimestre. Para T3-l los límites en el primer trimestre son de 2,33 a 3,84pg/ml, entre 2,04 y 3,51pg/ml en el segundo trimestre y entre 1,99 y 3,46pg/ml en el tercer trimestre.

Conclusión

: Los límites de referencia para nuestra población teniendo en cuenta los percentiles 3 y 97 están muy por debajo del recomendado por nuestro laboratorio de referencia, lo que obliga a redefinir estas concentraciones para evitar diagnosticar de forma incorrecta de hipotiroxinemia a la mujer gestante sana.

Palabras clave:
Hormonas tiroideas
Embarazo
Rangos de normalidad
Ingesta de yodo
Full text is only aviable in PDF
References
[1.]
M.L. Reuss, N. Paneth, J.A. Pinto-Martin, J.M. Lorenz, M. Susser.
The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age.
N Engl J Med, 334 (1996), pp. 821-827
[2.]
P. Santiago, R. Torres, J.A. Muela, G. Rojo, E. García, M.J. Garriga, et al.
Intelligence quotient and iodine intake: a cross- sectional study in children.
J Clin Endocrinol Metab, 89 (2004), pp. 3851-3857
[3.]
R. Lavado-Autric, E. Ausó, J.V. García-Velasco, M.C. Arufe, F. Escobar del Rey, G. Morreale de Escobar.
Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny.
J Clin Invest, 111 (2003), pp. 1073-1082
[4.]
G. Morreale de Escobar, M.J. Obregón, F. Escobar del Rey.
Maternal thyroid hormones early in pregnancy and fetal brain development.
Best Pract Res Clin Endocrinol Metab, 18 (2008), pp. 225-248
[5.]
I. Velasco, M. Carreira, P. Santiago, J.A. Muela, E. García, B. Sánchez, et al.
Effect of iodine prophylaxis during pregnancy on neurocognitive development of children during the first two years of life.
J Clin Endocrinol Metab, 94 (2009), pp. 3234-3241
[6.]
P. Berbel, J.L. Mestre, A. Santamaría, I. Palazón, A. Franco, M. Graells, et al.
Delayed neurobehavioral development in children born to pregnant women with mild hypothyroxinemia during the first month of gestation: the importance of early iodine supplementation.
Thyroid., 19 (2009), pp. 511-519
[7.]
J. Enrichs, J.J. Bongers-Schokking, J.J. Schenk, A. Ghassabian, H.G. Schmidt, T.J. Visser, et al.
Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: The Generation R Study.
J Clin Endocrinol Metab, 95 (2010), pp. 4227-4234
[8.]
WHO, UNICEF, ICCIIDD, Assessment of iodine deficiency disorders, monitoring their elimination.
A guide for programme managers.
3rd ed, World Health Organization, (2007),
[9.]
D. Glinoer.
What happens to the normal thyroid during pregnancy.
Thyroid., 9 (1999), pp. 631-635
[10.]
J. Haddow, M. McClain, G. Llambert-Messerlian, G. Palomaki, J.A. Canick, J. Cleary-Goldman, et al.
Variability in thyroid stimulating hormone suppression by human chorionic gonadotropin during early pregnancy.
J Clin Endocrin Metab, 93 (2008), pp. 3341-3347
[11.]
E.N. Pearce, E. Oken, M.W. Gillman, S.L. Lee, B. Magnani, D. Platek, et al.
Association of first-trimester thyroid function test values with thyroperoxidase antibody status, smoking, and multivitamin use.
Endocr Pract, 14 (2008), pp. 33-39
[12.]
M. Abalovich, N. Amino, L.A. Barbour, R.H. Cobin, L.J. De Groot, D. Glinoer, et al.
Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab, 92 (2007), pp. S1-S47
[13.]
R. Negro, A. Schwartz, R. Gismondi, A. Tinelli, T. Mangieri, A. Stagnaro-Green.
Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy.
J Clin Endocrinol Metab, 95 (2010), pp. E44-E48
[14.]
J.C. Galofré, J.J. Corrales, B. Pérez, A. Cantón, N. Alonso, A. Pérez, et al.
Guía clínica para el diagnóstico y el tratamiento de la disfunción tiroidea subclínica en la gestación.
Endocrinol Nutr, 56 (2009), pp. 85-91
[15.]
BECKMAN ACCESS. Immuno Assay System. HYPERsensitive hTSH.
[16.]
J. Benotti, N. Benotti.
Protein bound Iodine, total iodine and protein and butanol extractable iodine by partial automation.
Clin Chem, 9 (1963), pp. 408-416
[17.]
H. Gharib, R.M. Tuttle, J. Baskin, L.H. Fish, P.A. Singer, M.T. McDermott.
Consensus Statement: Subclinical thyroid dysfunction: a joint statement on management from the American Thyroid Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society.
J Clin Endocrinol Metab., 90 (2005), pp. 581-585
[18.]
F. Debiève, S. Dulière, P. Bernard, C. Hubinont, P. De Nayer, C. Daumerie.
To treat or not to treat euthyroid autoimmune disorder during pregnancy?.
Gynecol Obstet Invest, 67 (2009), pp. 178-182
[19.]
R.K. Marwaha, S. Chopra, S. Gopalakrishnan, B. Sharma, R.S. Kanwar, A.A. Sastry, et al.
Establishment of reference range for thyroid hormones in normal pregnant Indian women.
[20.]
M. Rebagliato, M. Murcia, M. Espada, M. Álvarez Pedrerol, F. Bolúmar, J. Vioque, et al.
Iodine intake and maternal thyroid function during pregnancy.
Epidemiology, 21 (2010), pp. 62-69
[21.]
S.L. La’ulu, W.L. Roberts.
Second-trimester reference intervals for thyroid tests: the role of ethnicity.
Clin Chem, 53 (2007), pp. 1658-1664
[22.]
A.M. Leung, E.N. Pearce, L.E. Braverman.
Iodine content of prenatal multivitamins in the United States.
N Engl J Med, 26 (2009), pp. 939-940
[23.]
A. Maldonado, E. Guerrero, M.A. Rodríguez, J.M. Andrés, C. Frontela, M. Moreira, et al.
Yododeficiencia en mujeres gestantes del Área Sanitaria de Palencia (España).
Endocrinol Nutr, 56 (2009), pp. 452-457
[24.]
I. Domínguez, S. Reviriego, G. Rojo-Martínez, M.J. Valdés, R. Carrasco, I. Coronas, et al.
Déficit de yodo y función tiroidea en una población de mujeres embarazadas sanas.
Med Clin (Barc), 122 (2004), pp. 449-453
Copyright © 2011. Sociedad Española de Endocrinología y Nutrición
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos